Focused on advanced wound care and medical dressings, the company develops and manufactures products used to treat chronic and acute wounds, including ulcers, burns, and surgical injuries. Its portfolio is primarily marketed to hospitals, clinics, and home‑care providers across Europe and other inte...
No congressional trades have been disclosed for URgO (UR) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
No congressional trades found for this stock.